`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS, INC.,
`
`Petitioner,
`
`V.
`
`NOVARTIS PHARMA AG,
`
`NOVARTIS TECHNOLOGY LLC,
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`Case No. Unassigned
`US. Patent No. 9,220,631
`
`POWER OF ATTORNEY FOR PETITIONER
`
`REGENERON PHARMACEUTICALS, INC.
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Regeneron Pharmaceuticals,
`
`Inc., hereby appoints the following practitioners as their attorneys to transact all
`
`business in the United States Patent & Trademark Office connected to the above-
`
`captioned Inter Partes Review of U.S. Patent No. 9,220,631 :
`
`LEAD COUNSEL
`
`BACK-UP COUNSEE
`
`Elizabeth Stotland Weiswasser
`
`Reg. No. 55,721
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`
`
`
`New York, NY 10153
`elizabeth.Weiswasser@weil.com
`Phone: 212-310-8022
`
`Fax: 212—310—8007
`
`
`
`Anish R. Desai
`
`Reg. No. 73,760
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`
`New York, NY 10153
`anish.desai@weil.com
`Phone: 212-310-8730
`
`Fax: 212-310—8007
`
`Brian E. Ferguson
`Reg. No. 36,801
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, DC. 20036
`brian.ferguson@weil.com
`Phone: 202-682-7516
`
`
`
`Fax: 202-857-0940
`Christopher M. Pepe
`Reg. No. 73,851
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, DC. 20036
`christopher.pepe@weil.com
`Phone: 202-682-7018
`
`Fax: 202-857-0940
`
`Service E-mail:
`
`REGN.IPR. Servicer'gj 'weil.con1
`
`
`
`I Natalie C. Kennedy
`' Reg. No. 68,511
`Weil, Gotshal & Manges LLP
`| 767 Fifth Avenue
`
`New York, NY 10153
`natalie.kennedy@weil.com
`Phone: 212-310-8227
`
`Fax: 212-310-8007
`
`
`
`
`
`
`LEAD COUNSEL
`I
`BACK—UP COUNSEL
`Andrew P. Gesior
`
`
`
`
`
`Reg. No. 76,588
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`
`New York, NY 10153
`andrew.gesior@weil.com
`Phone: 212-310—8244
`
`Fax: 212—310—8007
`
`Priyata Y. Patel
`Reg. No. 76,861
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`
`Washington, DC. 20036
`priyata.patel@weil.com
`Phone: 202-682-7041
`
`
`
`
`Fax: 202—857—0940
`
`The undersigned has the authority to execute this document on behalf of
`
`Petitioner Regeneron Pharmaceuticals, Inc.
`
`Dated: July/
`
`,2020
`
`Vice President, Associate General Counsel
`Regeneron Pharmaceuticals, Inc.
`
`